cetylpyridinium chloride anhydrous has been researched along with Lymphoma, B-Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horiuchi, H; Imashuku, S; Ishii, E; Kawa, K; Kinukawa, N; Miura, I; Nakamura, S; Ohga, S; Ohshima, K; Oshimi, K; Takada, K; Tsuda, H; Yamamoto, K; Yasukawa, M | 1 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and Lymphoma, B-Cell
| Article | Year |
|---|---|
Nationwide survey of hemophagocytic lymphohistiocytosis in Japan.
Topics: Adolescent; Adult; Age Factors; Autoimmune Diseases; Child; Child, Preschool; Epstein-Barr Virus Infections; Female; Health; Humans; Infant; Japan; Lymphohistiocytosis, Hemophagocytic; Lymphoma, B-Cell; Male; Middle Aged; Survival Analysis | 2007 |